Institute for OneWorld Health to Create Innovative and Sustainable Disease Control Program

SAN FRANCISCO -- The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., today announced that it has received a US$30 million grant from the Bill & Melinda Gates Foundation to initiate and evaluate  the impact of a pilot program to dramatically reduce morbidity and mortality from visceral leishmaniasis (VL) in the rural communities of India, Bangladesh, and Nepal. 

To read the full press release, visit the OneWorld Health Web site.